Tag: NYSE:WX

BioTech, Stock Movers

BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Myriad Genetics (NASDAQ:MYGN) is lower after the molecular diagnostic company disclosed in a regulatory filing Tuesday that the U.S. District Court for the District of Utah has denied the company’s motion for preliminary injunctive relief against Ambry Genetics’s sale of certain testing services that MYGN believes infringes on its patents. Shares are down 9.80% at $34.04, with a 52-week range of $20.02 – $39.15. Myriad … Continue reading BioTech in Focus: Myriad Genetics (NASDAQ:MYGN), Cantel Medical (NYSE:CMN), WuXi (NYSE:WX)

Richard Atkins
news

Investor Alerts: PFSweb (NASDAQ:PFSW), TCP Capital (NASDAQ:TCPC), Warren Resources (NASDAQ:WRES), WuXi Pharmatech Cayman Inc. (NYSE:WX)

PFSweb (NASDAQ:PFSW) is higher after the company on Thursday reported better-than-expected financial results for Q4. Shares are up 3.18% at $9.09 in late-morning Thursday trade, near its 52-week high of $9.60. The eCommerce firm reported Q4 non-GAAP earnings of $0.06 per share, compared with the prior-year period’s $0.07 per share. The Capital IQ consensus estimate was for $0.02 per share. PFSweb (NASDAQ:PFSW)’s GAAP loss for … Continue reading Investor Alerts: PFSweb (NASDAQ:PFSW), TCP Capital (NASDAQ:TCPC), Warren Resources (NASDAQ:WRES), WuXi Pharmatech Cayman Inc. (NYSE:WX)

Chris Lewis